Brief: Pharmena receives patent for drug against arteriosclerosis
Nov 10 (Reuters) - Pharmena SA PHR.WA :
* Receives patent from the US patent office for its 1-
methylnicotinamide (1-MNA) drug against arteriosclerosis
Source text for Eikon: ID:nEB1072109
Further company coverage: PHR.WA
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920))
Keywords: PHARMENA/BRIEF
Recent news on Pharmena SA
See all newsBrief: Pharmena Makes Cession Of Rights And Obligations From Unit Menavitin
Brief: Pharmena Signs Two Distribution Deals For US, Canada And Mexico Markets
Brief: Pharmena 9-Month Net Loss Narrows To 0.7 Mln Zlotys
Brief: Pharmena Plans To Separate Dermocosmetic Business
Brief: Pharmena H1 Net Loss Narrows To 0.6 Mln Zlotys